Medical Synergy Collaboration with VS Diagnostics (VSD) and Healthcare Practice Sale (HPS)
Medical Synergy Collaboration with VS Diagnostics (VSD) and Healthcare Practice Sale (HPS)
Medical Synergy Collaboration with VS Diagnostics (VSD) and Healthcare Practice Sale (HPS)
Medical Synergy Collaboration with VS Diagnostics (VSD) and Healthcare Practice Sale (HPS)
Medical Synergy is working with VS Diagnostics (VSD) and Healthcare Practice Sale (HPS) to prove the hypothesis that integrating VSD into medical practices can significantly enhance their value, potentially increasing sale prices by $1 million or more. Medical Synergy seeks to recruit medical practices willing to incorporate VSD into daily operations. If successful, this strategy should position VSD for a company-wide sale exceeding $250 million.
VSD is a leading ancillary program in the medical field, playing a crucial role in saving lives while reducing hospital admissions. It has maintained a stable and reliable reimbursement structure for over 15 years, ensuring a sustainable revenue stream for participating practices. Additionally, medical necessity for testing can be established for a high percentage of patients, further reinforcing its value.